Menstruation Disturbances
15
2
2
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
6.7%
1 terminated out of 15 trials
88.9%
+2.4% vs benchmark
27%
4 trials in Phase 3/4
38%
3 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (15)
Transdermal Ethinyl Estradiol and Norelgestromin for Irregular Bleeding in Contraceptive Implant Users
Impact of MEnstruation on Glycemic Response and Exercise In Females With Type 1 Diabetes
Comparison of Menstrual Function Among Sprinters, Long Marathon Runners, and Non-Athletic Females
The Menstrual Distress Questionnaire (MEDI-Q) Reliability and Validity of the Turkish Version
A Treatment Study for Premenstrual Syndrome (PMS)
Energy Restriction and Hormones in Premenopausal Women
Bioenergetics of Exercise-Induced Menstrual Disturbances
Lifestyle Influence on Primary Dysmenorrhea
Investigation of Female Reproductive Hormone Dynamics During Adolescence
Tamoxifen for the Treatment of Unfavorable Bleeding in Contraceptive Implant Users
Continuous Use of the Contraceptive Patch and the Personal Economic Impact.
Frequency of Female Athlete Triad Among Elite Female Athlete of Iran in Different Sport in 2007
Ethinyl Estradiol and Cyproterone Acetate in Irregular Menstruation
Study Evaluating Combination of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) in Premenstrual Dysphoric Disorder
Study Evaluating Combination of Levonorgestrel and Ethinyl Estradiol in Pre-Menstrual Dysphoric Disorder